Chromosomal Microarray Genetic Testing

Our team helps you every step of the way

Best-in-class Chromosomal Microarray genetic testing for children with autism spectrum disorder and developmental delay

FirstStep^Dx PLUS is a Chromosomal Microarray (CMA) designed to identify an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability. Lineagen makes genetic testing easy and accessible for everyone. Your patient's sample is collected with a painless, non-invasive cheek swab, and Lineagen handles all of the insurance correspondence followed by delivery of a thorough, yet easy-to-read report.

FirstStep^Dx PLUS Chromosomal Microarray (CMA) genetic testing service includes:

Highest detection rate and widest range of genetic diagnoses for children with developmental delay, including autism spectrum disorder
Personalized genetic counseling and clinical support
Comprehensive support of the insurance process
Detailed clinical report with extensive medical references and an easily understandable, focused report

Optimization of the FirstStepDx PLUS CMA results in a 30% detection rate of clinically relevant results, the highest detection rate of any clinically available CMA test.

Learn more

How can FirstStep^Dx PLUS help my patients?

FirstStep^Dx PLUS can detect an underlying genetic cause of autism spectrum disorder and developmental delay, which means opening up new treatment options and pointing towards necessary evaluations. A Chromosomal Microarray for children with autism spectrum disorder and developmental delay can pinpoint one of hundreds of known conditions that may be responsible for your patient's clinical features. New management options and treatments should be considered, including evaluations for co-occurring medical issues, and recurrence risk for the family.

See benefits

What makes FirstStep^Dx PLUS different?

Best-in-class Chromosomal Microarray Genetic Test

FirstStep^Dx PLUS Chromosomal Microarray (CMA) genetic testing for children with autism spectrum disorder and developmental delay is optimized with unique detection sites^{1, 2} to increase detection rate, as well as rule out many other conditions.

Additional validated detection sites increase detection rate
Highest detection rate (30%) of any clinically available CMA test
Rules out hundred of genetic conditions
Non-invasive DNA collection produces superior clinical results - improved detection of certain mosaic conditions³

Comprehensive Clinical Support

Pre- and post-test genetic counseling
Individualized patient reports with a dedicated provider section and an easy-to-read family section
Reports include a comprehensive list of relevant literature for optimal result interpretation

Personalized Insurance Assistance

Lineagen handles all insurance correspondence, from pre-authorizations to appeals
Expert team of insurance specialists
Various assistance programs and payment plans and other financial assistance options

Highest
detection rate

Painless
cheek swab

Easy to understand
test results report

More detail

How to order

Lineagen helps healthcare providers and patients understand their test results.

Our genetic counselors explain the test results in a thorough, but easy-to-understand report. Even if this is your first genetic test, you'll have no trouble understanding the results and advising parents on their options.

The report also includes a section for parents and, if there are any questions, you have unlimited access to our genetic counselors.

View sample report

Lineagen handles every step of the insurance process for you.

For some healthcare providers, the most challenging part of ordering a genetic test is the long process of authorizations and appeals.

Lineagen takes the insurance burden from providers and their staff by assisting in every step of the process. This way providers can focus on direct patient care.

Take the insurance burden off

There are hundreds or even thousands of genetic syndromes, many of which have overlapping features, which make it very difficult without the use of genetic testing technology to pinpoint exactly which syndrome a patient may have.

Rena Vanzo